InvestSMART

Nyrada Inc (ASX: NYR) - Announcements

Current share price for NYR : $0.470 0.01 (2.08%)+

ASX company news and announcements for Nyrada Inc (NYR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nyrada Inc (NYR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nyrada Inc (NYR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nyrada Inc (NYR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$122 Initial Director's Interest Notice - JB 8 Oct 2025 9:43AM $0.295 $0.470 risen by 59.32%
$122 Nyrada Board Transition and CEO Remuneration Review 8 Oct 2025 9:41AM $0.295 $0.470 risen by 59.32%
$122 Cleansing Statement 2 Oct 2025 4:31PM $0.320 $0.470 risen by 46.88%
$122 Application for quotation of securities - NYR 2 Oct 2025 4:28PM $0.320 $0.470 risen by 46.88%
$122 Nyrada 2025 Equity Incentive Plan 1 Oct 2025 8:51AM $0.305 $0.470 risen by 54.10%
$122 Xolatryp Achieves Key Clinical Milestone 29 Sep 2025 8:30AM $0.285 $0.470 risen by 64.91%
$122 Xolatryp Protects Cells through Mitochondrial Stabilisation 16 Sep 2025 9:53AM $0.250 $0.470 risen by 88%
$122 Change in substantial holding - M Azzi 11 Sep 2025 1:02PM $0.280 $0.470 risen by 67.86%
$122 Cleansing Statement 9 Sep 2025 4:35PM $0.285 $0.470 risen by 64.91%
$122 Application for quotation of securities - NYR 9 Sep 2025 4:31PM $0.285 $0.470 risen by 64.91%
$122 Cleansing Statement 22 Aug 2025 7:03PM $0.270 $0.470 risen by 74.07%
$122 Application for quotation of securities - NYR 22 Aug 2025 6:56PM $0.270 $0.470 risen by 74.07%
$122 Notification regarding unquoted securities - NYR 22 Aug 2025 6:52PM $0.270 $0.470 risen by 74.07%
$122 Full Year Results FY2025 22 Aug 2025 9:41AM $0.270 $0.470 risen by 74.07%
$122 Annual Report for year ended 30 June 2025 22 Aug 2025 9:40AM $0.270 $0.470 risen by 74.07%
$122 Appendix 4G and Corporate Governance Statement 22 Aug 2025 9:38AM $0.270 $0.470 risen by 74.07%
$122 Preliminary Final Report 22 Aug 2025 9:37AM $0.270 $0.470 risen by 74.07%
$122 Securities Trading Policy 22 Aug 2025 9:33AM $0.270 $0.470 risen by 74.07%
$122 Notification regarding unquoted securities - NYR 20 Aug 2025 4:38PM $0.270 $0.470 risen by 74.07%
$122 Response to ASX Cleansing Notice Timing Letter 14 Aug 2025 9:44AM $0.300 $0.470 risen by 56.67%
$122 Cleansing Statement 13 Aug 2025 6:23PM $0.300 $0.470 risen by 56.67%
$122 Application for quotation of securities - NYR 13 Aug 2025 6:20PM $0.300 $0.470 risen by 56.67%
$122 NYR Appoints Consultant Cardiologist for Phase IIa Trial 13 Aug 2025 9:15AM $0.295 $0.470 risen by 59.32%
$122 Cleansing Statement 11 Aug 2025 9:53AM $0.300 $0.470 risen by 56.67%
$122 Application for quotation of securities - NYR 11 Aug 2025 9:52AM $0.300 $0.470 risen by 56.67%

126 - 150 of 518 results

Page 6 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.